imiloxan has been researched along with medetomidine in 1 studies
| Studies (imiloxan) | Trials (imiloxan) | Recent Studies (post-2010) (imiloxan) | Studies (medetomidine) | Trials (medetomidine) | Recent Studies (post-2010) (medetomidine) |
|---|---|---|---|---|---|
| 45 | 0 | 21 | 1,335 | 296 | 444 |
| Protein | Taxonomy | imiloxan (IC50) | medetomidine (IC50) |
|---|---|---|---|
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 3.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takano, M; Takano, Y; Yaksh, TL | 1 |
1 other study(ies) available for imiloxan and medetomidine
| Article | Year |
|---|---|
The effect of intrathecally administered imiloxan and WB4101: possible role of alpha 2-adrenoceptor subtypes in the spinal cord.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Clonidine; Dioxanes; Dose-Response Relationship, Drug; Imidazoles; Injections, Spinal; Male; Medetomidine; Nociceptors; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Spinal Cord | 1992 |